Meribank Biotech Co., Ltd (TPEX:4724)

Meribank Biotech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	165.09	399.46	85.16	192.15	51.4
Short-Term Investments	-	-	122.7	94.1	45.9
Cash & Short-Term Investments	165.09	399.46	207.86	286.25	97.3
Cash Growth	-58.67%	92.18%	-27.39%	194.21%	-39.10%
Accounts Receivable	158.22	128.63	146.97	147.53	136.06
Other Receivables	8.82	6.5	5.47	1.63	0.14
Receivables	167.04	135.13	152.44	149.17	136.2
Inventory	11.24	6.91	8.45	3.6	2.94
Prepaid Expenses	49.6	28.61	24.13	19.87	19.03
Other Current Assets	0.34	0.09	0.02	0.11	-
Total Current Assets	393.31	570.19	392.9	458.99	255.46
Property, Plant & Equipment	479.46	162.06	178.19	190.76	210.04
Long-Term Investments	59.57	59.56	25.22	44.45	18.89
Goodwill	282.18	2.87	-	-	-
Other Intangible Assets	584.09	31.69	10.22	1.09	1.92
Long-Term Deferred Tax Assets	3.8	2.48	-	-	-
Other Long-Term Assets	879.54	233.17	239.8	252.03	243.65
Total Assets	2,682	1,062	846.33	947.32	729.97
Accounts Payable	13.08	12.32	7.6	4.75	4.99
Accrued Expenses	53.9	50.63	45.84	44.57	44.66
Current Portion of Long-Term Debt	7.32	-	-	-	-
Current Portion of Leases	70.85	19.23	21.58	18.25	19.99
Current Unearned Revenue	27.33	17.56	14.76	12.97	12.3
Other Current Liabilities	59.76	27.17	19.28	15.34	16.96
Total Current Liabilities	232.23	126.91	109.07	95.87	98.9
Long-Term Debt	162.88	-	-	-	-
Long-Term Leases	701.79	14.81	24.25	34.73	49.93
Long-Term Unearned Revenue	258.41	245.7	236.52	228.14	195.56
Long-Term Deferred Tax Liabilities	99.83	1.38	0.65	-	-
Other Long-Term Liabilities	9.42	2.02	2.05	2.53	2.95
Total Liabilities	1,465	390.81	372.53	361.27	347.34
Common Stock	879.76	709.76	627.76	627.76	526.71
Additional Paid-In Capital	710.82	233.2	203.24	203.74	2.88
Retained Earnings	-373.23	-272.2	-350.09	-247.58	-148.39
Comprehensive Income & Other	-11.62	-9.04	-9.71	2.12	1.43
Total Common Equity	1,206	661.73	471.2	586.05	382.64
Minority Interest	11.65	9.46	2.59	-	-
Shareholders' Equity	1,217	671.2	473.79	586.05	382.64
Total Liabilities & Equity	2,682	1,062	846.33	947.32	729.97
Total Debt	942.84	34.04	45.83	52.97	69.92
Net Cash (Debt)	-777.75	365.42	162.03	233.28	27.38
Net Cash Growth	-	125.53%	-30.54%	752.06%	-79.34%
Net Cash Per Share	-9.78	5.81	2.58	3.87	0.52
Filing Date Shares Outstanding	87.98	70.98	62.78	62.78	52.67
Total Common Shares Outstanding	87.98	70.98	62.78	62.78	52.67
Working Capital	161.08	443.27	283.83	363.12	156.56
Book Value Per Share	13.71	9.32	7.51	9.34	7.26
Tangible Book Value	339.46	627.17	460.98	584.96	380.72
Tangible Book Value Per Share	3.86	8.84	7.34	9.32	7.23
Land	214.7	41.08	41.08	41.08	41.08
Buildings	107.62	53.84	53.23	52.95	52.95
Machinery	96.57	76.56	61.45	62.83	61.07

Updated Aug 9, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.